Report on IMMUNO-model Workshop: Harmonizing In Vivo Models of Immunotherapy – Past, Present and Future Directions

Report on IMMUNO-model Workshop: Harmonizing In Vivo Models of Immunotherapy – Past, Present and Future Directions

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

IMMUNO-model Workshop: Harmonizing In Vivo Models of Immunotherapy – Past, Present and Future Directions (WG2) took place on 7–8 April 2025 in Bergen, Norway, bringing together 53 participants in a hybrid format to discuss in vivo models for immunotherapy. The event focused on the goals of Working Group 2 (WG2): advancing preclinical models, fostering data sharing, and strengthening translational collaboration in immuno-oncology.

The workshop opened with welcome remarks from WG2 Leader Emmet Mc Cormack and featured an engaging scientific program with excellent presentations from early-career and senior researchers. Speakers addressed diverse topics, including zebrafish and canine companion models, humanized mice, nanoparticle delivery systems and bone marrow organoids. The workshop effectively showcased a broad range of in vivo immunotherapy models enabling participants to reflect on common strengths and limitations such as predictive power, clinical relevance, and translational potential. Invited speakers included Rita Fior (Portugal), Johanne Jacobsen (Norway), and Enni Markkanen (Switzerland), whose presentations highlighted innovative approaches and future directions in modeling immune responses to cancer.

Sessions were moderated by Emmet Mc Cormack, Calum Leitch, and Vibeke Samuelsen Fosse (University of Bergen), and included contributions from academia, clinical institutions, and industry. Poster sessions and coffee breaks provided additional opportunities for networking and collaboration. Virtual participants engaged via Zoom live streams and chat function, which enabled interaction and exchanges throughout the sessions.

Day 2 featured a recap of key insights and a strategic planning session focused on defining WG2 objectives and identifying common challenges in in vivo modeling for immunotherapy. The engaging discussions also offered a valuable opportunity for both early-career and senior researchers to openly reflect on the challenges and opportunities of academic career development, leading to meaningful insights and new connections.

The workshop successfully strengthened the IMMUNO-model network, encouraged new collaborations, and laid the groundwork for a joint WG2 publication.

Feedback of participant:

“The workshop was extremely well organised.

Most of the talks were very very interesting, with a large input from female presenters and from early career presenters.

Discussion was very good both officially  during the workshop and informally during the evening out and the breaks. Maybe a small negative – the signposting to the workshop on the first day was small and I missed it and walked right past it – luckily a helpful student brought us directly to the building ( we were already very close)..”

We thank the organizers Prof. Emmet Mc Cormack, Calum Leitch and  Zinayida Fandalyuk from University of Bergen, Norway, for their great work and effort!

Latest Updates

We invite cancer patients, relatives, and caregivers to join our patient webinar, where we will explain the basics of immunotherapy, discuss current challenges, and highlight how patient involvement is essential...
We’re excited to share the latest addition to the IMMUNOmodel Knowledge Hub:👉 “Invasion/Chemotaxis-on-chip” by Devrim Pesen Okvur🔗 https://osf.io/yws9r/files/7sqye  This step-by-step protocol details how to study cell invasion and chemotaxis in 3D...
Date and place: 20-22 May 2026, National Institute of Biology, Ljubljana, Slovenia We are delighted to announce the Final IMMUNO-model Annual Conference – Building Bridges in Cancer Immunotherapy Modelling, where we...
STSM: Short Term Scientific Mission Visit to a host organization located in a different country than the country of affiliation by a researcher or innovator for specific work to be...
01. Past Activities Webinar 10: Natural Killer Cells in action: from bench to bedside The video of the webinar entitled: “Natural Killer Cells in action: from bench to bedside” can...
A new IMMUNOmodel Knowledge Hub protocol is now available:👉 “Mathematical Models for Tumour Growth Based on Ordinary Differential Equations” by Peter Rashkov🔗 https://osf.io/ut49k/files/zdwrs  This protocol shows how to model tumour growth...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter